In the TCGA cohort, the four distinct subtypes of melanoma (TCGA-SKCM), BRAF, NRAS, triple wild type, and NF1 put together, constitute only 25% of the samples, leaving ~75% with no clear mutation association. The gene discussed is NRAS; the disease is melanoma.